Industry: Chemical & Material
Published Date: 2026-07-14
Pages: 150 Pages
Report ld: 6921296
Request Sample
Customized Report
The global market for Beneficial Bacteria was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The North American market for Beneficial Bacteria was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Beneficial Bacteria was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Beneficial Bacteria was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Beneficial Bacteria market include Danisco, Kerry, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia, Yakult, Novozymes, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Beneficial Bacteria, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Beneficial Bacteria market size, estimations, and forecasts are presented in terms of sales volume (K MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Beneficial Bacteria.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Beneficial Bacteria manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Beneficial Bacteria sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Beneficial Bacteria sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Beneficial Bacteria Product Introduction
1.2 Global Beneficial Bacteria Market Size Forecast
1.2.1 Global Beneficial Bacteria Sales Value (2021–2032)
1.2.2 Global Beneficial Bacteria Sales Volume (2021–2032)
1.2.3 Global Beneficial Bacteria Sales Price (2021–2032)
1.3 Beneficial Bacteria Market Trends & Drivers
1.3.1 Beneficial Bacteria Industry Trends
1.3.2 Beneficial Bacteria Market Drivers & Opportunities
1.3.3 Beneficial Bacteria Market Challenges
1.3.4 Beneficial Bacteria Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Beneficial Bacteria Players Revenue Ranking (2025)
2.2 Global Beneficial Bacteria Revenue by Company (2021–2026)
2.3 Global Beneficial Bacteria Sales Volume Ranking of Players (2025)
2.4 Global Beneficial Bacteria Sales Volume by Company (2021–2026)
2.5 Global Beneficial Bacteria Average Price by Company (2021–2026)
2.6 Key Manufacturers Beneficial Bacteria Manufacturing Base and Headquarters
2.7 Key Manufacturers Beneficial Bacteria Product Offerings
2.8 Key Manufacturers Start of Mass Production of Beneficial Bacteria
2.9 Beneficial Bacteria Market Competitive Analysis
2.9.1 Beneficial Bacteria Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Beneficial Bacteria Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Beneficial Bacteria revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Beneficial Bacteria Market Classification
3.1 Introduction by Type
3.1.1 Bifidobacterium
3.1.2 Lactobacillus
3.1.3 Others
3.1.4 Global Beneficial Bacteria Sales Value by Type
3.1.4.1 Global Beneficial Bacteria Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Beneficial Bacteria Sales Value, by Type (2021–2032)
3.1.4.3 Global Beneficial Bacteria Sales Value, by Type (%), 2021–2032
3.1.5 Global Beneficial Bacteria Sales Volume by Type
3.1.5.1 Global Beneficial Bacteria Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Beneficial Bacteria Sales Volume, by Type (2021–2032)
3.1.5.3 Global Beneficial Bacteria Sales Volume, by Type (%), 2021–2032
3.1.6 Global Beneficial Bacteria Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food & Beverage
4.1.2 Drugs
4.1.3 Dietary Supplements
4.1.4 Others
4.2 Global Beneficial Bacteria Sales Value by Application
4.2.1 Global Beneficial Bacteria Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Beneficial Bacteria Sales Value, by Application (2021–2032)
4.2.3 Global Beneficial Bacteria Sales Value, by Application (%), 2021–2032
4.3 Global Beneficial Bacteria Sales Volume by Application
4.3.1 Global Beneficial Bacteria Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Beneficial Bacteria Sales Volume, by Application (2021–2032)
4.3.3 Global Beneficial Bacteria Sales Volume, by Application (%), 2021–2032
4.4 Global Beneficial Bacteria Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Beneficial Bacteria Sales Value by Region
5.1.1 Global Beneficial Bacteria Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Beneficial Bacteria Sales Value by Region (2021–2026)
5.1.3 Global Beneficial Bacteria Sales Value by Region (2027–2032)
5.1.4 Global Beneficial Bacteria Sales Value by Region (%), 2021–2032
5.2 Global Beneficial Bacteria Sales Volume by Region
5.2.1 Global Beneficial Bacteria Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Beneficial Bacteria Sales Volume by Region (2021–2026)
5.2.3 Global Beneficial Bacteria Sales Volume by Region (2027–2032)
5.2.4 Global Beneficial Bacteria Sales Volume by Region (%), 2021–2032
5.3 Global Beneficial Bacteria Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Beneficial Bacteria Sales Value, 2021–2032
5.4.2 North America Beneficial Bacteria Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Beneficial Bacteria Sales Value, 2021–2032
5.5.2 Europe Beneficial Bacteria Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Beneficial Bacteria Sales Value, 2021–2032
5.6.2 Asia Pacific Beneficial Bacteria Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Beneficial Bacteria Sales Value, 2021–2032
5.7.2 South America Beneficial Bacteria Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Beneficial Bacteria Sales Value, 2021–2032
5.8.2 Middle East & Africa Beneficial Bacteria Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Beneficial Bacteria Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Beneficial Bacteria Sales Value and Sales Volume
6.2.1 Key Countries/Regions Beneficial Bacteria Sales Value, 2021–2032
6.2.2 Key Countries/Regions Beneficial Bacteria Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Beneficial Bacteria Sales Value, 2021–2032
6.3.2 United States Beneficial Bacteria Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Beneficial Bacteria Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Beneficial Bacteria Sales Value, 2021–2032
6.4.2 Europe Beneficial Bacteria Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Beneficial Bacteria Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Beneficial Bacteria Sales Value, 2021–2032
6.5.2 China Beneficial Bacteria Sales Value by Type (%), 2025 vs 2032
6.5.3 China Beneficial Bacteria Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Beneficial Bacteria Sales Value, 2021–2032
6.6.2 Japan Beneficial Bacteria Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Beneficial Bacteria Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Beneficial Bacteria Sales Value, 2021–2032
6.7.2 South Korea Beneficial Bacteria Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Beneficial Bacteria Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Beneficial Bacteria Sales Value, 2021–2032
6.8.2 Southeast Asia Beneficial Bacteria Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Beneficial Bacteria Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Beneficial Bacteria Sales Value, 2021–2032
6.9.2 India Beneficial Bacteria Sales Value by Type (%), 2025 vs 2032
6.9.3 India Beneficial Bacteria Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Danisco
7.1.1 Danisco Company Information
7.1.2 Danisco Introduction and Business Overview
7.1.3 Danisco Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Danisco Beneficial Bacteria Product Offerings
7.1.5 Danisco Recent Developments
7.2 Kerry
7.2.1 Kerry Company Information
7.2.2 Kerry Introduction and Business Overview
7.2.3 Kerry Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Kerry Beneficial Bacteria Product Offerings
7.2.5 Kerry Recent Developments
7.3 Lallemand
7.3.1 Lallemand Company Information
7.3.2 Lallemand Introduction and Business Overview
7.3.3 Lallemand Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Lallemand Beneficial Bacteria Product Offerings
7.3.5 Lallemand Recent Developments
7.4 China-Biotics
7.4.1 China-Biotics Company Information
7.4.2 China-Biotics Introduction and Business Overview
7.4.3 China-Biotics Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 China-Biotics Beneficial Bacteria Product Offerings
7.4.5 China-Biotics Recent Developments
7.5 Nestle
7.5.1 Nestle Company Information
7.5.2 Nestle Introduction and Business Overview
7.5.3 Nestle Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Nestle Beneficial Bacteria Product Offerings
7.5.5 Nestle Recent Developments
7.6 Danone
7.6.1 Danone Company Information
7.6.2 Danone Introduction and Business Overview
7.6.3 Danone Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Danone Beneficial Bacteria Product Offerings
7.6.5 Danone Recent Developments
7.7 Probi
7.7.1 Probi Company Information
7.7.2 Probi Introduction and Business Overview
7.7.3 Probi Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Probi Beneficial Bacteria Product Offerings
7.7.5 Probi Recent Developments
7.8 BioGaia
7.8.1 BioGaia Company Information
7.8.2 BioGaia Introduction and Business Overview
7.8.3 BioGaia Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 BioGaia Beneficial Bacteria Product Offerings
7.8.5 BioGaia Recent Developments
7.9 Yakult
7.9.1 Yakult Company Information
7.9.2 Yakult Introduction and Business Overview
7.9.3 Yakult Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Yakult Beneficial Bacteria Product Offerings
7.9.5 Yakult Recent Developments
7.10 Novozymes
7.10.1 Novozymes Company Information
7.10.2 Novozymes Introduction and Business Overview
7.10.3 Novozymes Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Novozymes Beneficial Bacteria Product Offerings
7.10.5 Novozymes Recent Developments
7.11 Valio
7.11.1 Valio Company Information
7.11.2 Valio Introduction and Business Overview
7.11.3 Valio Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Valio Beneficial Bacteria Product Offerings
7.11.5 Valio Recent Developments
7.12 Glory Biotech
7.12.1 Glory Biotech Company Information
7.12.2 Glory Biotech Introduction and Business Overview
7.12.3 Glory Biotech Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Glory Biotech Beneficial Bacteria Product Offerings
7.12.5 Glory Biotech Recent Developments
7.13 Ganeden
7.13.1 Ganeden Company Information
7.13.2 Ganeden Introduction and Business Overview
7.13.3 Ganeden Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Ganeden Beneficial Bacteria Product Offerings
7.13.5 Ganeden Recent Developments
7.14 Morinaga Milk Industry
7.14.1 Morinaga Milk Industry Company Information
7.14.2 Morinaga Milk Industry Introduction and Business Overview
7.14.3 Morinaga Milk Industry Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Morinaga Milk Industry Beneficial Bacteria Product Offerings
7.14.5 Morinaga Milk Industry Recent Developments
7.15 Sabinsa
7.15.1 Sabinsa Company Information
7.15.2 Sabinsa Introduction and Business Overview
7.15.3 Sabinsa Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Sabinsa Beneficial Bacteria Product Offerings
7.15.5 Sabinsa Recent Developments
7.16 Greentech
7.16.1 Greentech Company Information
7.16.2 Greentech Introduction and Business Overview
7.16.3 Greentech Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 Greentech Beneficial Bacteria Product Offerings
7.16.5 Greentech Recent Developments
7.17 Bioriginal
7.17.1 Bioriginal Company Information
7.17.2 Bioriginal Introduction and Business Overview
7.17.3 Bioriginal Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.17.4 Bioriginal Beneficial Bacteria Product Offerings
7.17.5 Bioriginal Recent Developments
7.18 Biosearch Life
7.18.1 Biosearch Life Company Information
7.18.2 Biosearch Life Introduction and Business Overview
7.18.3 Biosearch Life Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.18.4 Biosearch Life Beneficial Bacteria Product Offerings
7.18.5 Biosearch Life Recent Developments
7.19 UAS Laboratories
7.19.1 UAS Laboratories Company Information
7.19.2 UAS Laboratories Introduction and Business Overview
7.19.3 UAS Laboratories Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.19.4 UAS Laboratories Beneficial Bacteria Product Offerings
7.19.5 UAS Laboratories Recent Developments
7.20 Synbiotech
7.20.1 Synbiotech Company Information
7.20.2 Synbiotech Introduction and Business Overview
7.20.3 Synbiotech Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2021–2026)
7.20.4 Synbiotech Beneficial Bacteria Product Offerings
7.20.5 Synbiotech Recent Developments
8 Industry Chain Analysis
8.1 Beneficial Bacteria Industrial Chain
8.2 Beneficial Bacteria Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Beneficial Bacteria Sales Model
8.5.2 Sales Channels
8.5.3 Beneficial Bacteria Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Beneficial Bacteria market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 150
USD 2900.00
(Single User License)
The global Beneficial Bacteria market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 175
USD 4900.00
(Single User License)
The global Beneficial Bacteria market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 110
USD 4250.00
(Single User License)
The global market for Beneficial Bacteria was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 142
USD 3950.00
(Single User License)
The global market for Beneficial Bacteria was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 107
USD 2900.00
(Single User License)
The global Beneficial Bacteria market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-26
Pages: 129
USD 4900.00
(Single User License)
The global Beneficial Bacteria market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 150
The global Beneficial Bacteria market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 175
The global Beneficial Bacteria market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 110
The global market for Beneficial Bacteria was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 142
The global market for Beneficial Bacteria was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 107
The global Beneficial Bacteria market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-26
Pages: 129
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now